Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Published 2014 View Full Article

Authors

Keywords

Journal

MOLECULAR CANCER THERAPEUTICS

Volume 13, Issue 6, Pages 1537-1548

Publisher

American Association for Cancer Research (AACR)

Online

2014-04-09

DOI

10.1158/1535-7163.mct-13-0926

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

MOLECULAR CANCER THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.